{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:30Z","timestamp":1761100710855},"reference-count":13,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T00:00:00Z","timestamp":1096416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Some patients requiring acid suppression may be unable to take oral medications.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To compare the gastric acid inhibition effects of lansoprazole 30\u2003mg administered either intravenous or orally in erosive oesophagitis patients.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002The study included 87 <jats:italic>Helicobacter pylori<\/jats:italic>\u2010negative patients with erosive oesophagitis. Each patient received 7\u2003days of lansoprazole 30\u2003mg orally prior to being randomized in a 3:1 fashion to intravenously lansoprazole 30\u2003mg or intravenously placebo for 7\u2003days. Basal acid output and pentagastrin\u2010stimulated acid output were measured on days 8, 9 and 15.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Median pentagastrin\u2010stimulated acid output was 7.2\u2003mmol\/h after 7\u2003days of oral lansoprazole. The median pentagastrin\u2010stimulated acid output increased to 7.6\u2003mmol\/h after 7\u2003days of intravenous lansoprazole compared with 26.9\u2003mmol\/h after intravenous placebo (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001).<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Lansoprazole 30\u2003mg administered intravenous was equivalent to the 30\u2003mg oral capsule in gastric acid suppression. Intravenous proton pump inhibitor therapy represents an important treatment option for those with acid\u2010related diseases who are unable to take oral medications.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02188.x","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T12:51:53Z","timestamp":1097585513000},"page":"883-889","source":"Crossref","is-referenced-by-count":13,"title":["Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis"],"prefix":"10.1111","volume":"20","author":[{"given":"T. O. G.","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Q.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.\u2010L.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. L.","family":"Pilmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,12]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61790-X"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001574-199807000-00011"},{"key":"e_1_2_15_4_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1155\/1998\/925346","article-title":"The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts","volume":"12","author":"Thomson AB","year":"1998","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00101.x"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323020-00001"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05532.x"},{"key":"e_1_2_15_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200222020-00004"},{"key":"e_1_2_15_9_2","first-page":"1758","article-title":"Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2\u2010RA therapy. The Lansoprazole Maintenance Study Group","volume":"91","author":"Sontag SJ","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.14156000.x"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01105.x"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01942.x"},{"key":"e_1_2_15_13_2","first-page":"2","volume-title":"Clinical Investigation of Gastric Function","author":"Kovacs TOG","year":"1990"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00831.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02188.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02188.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02188.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:17:36Z","timestamp":1697231856000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02188.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02188.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02188.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}